We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Breast Cancer Treatment – Prof. Andrew Tutt on the OlympiA Trial

Video  
Published: June 14, 2021
 
| Taken from The Institute of Cancer Research, YouTube
The results of the OlympiA clinical trial, involving ICR researchers, shows giving the drug olaparib for one year to breast cancer patients with inherited BRCA mutations, after they have completed initial treatment, reduced the chance of their breast cancer returning.

Professor Andrew Tutt, Head of Breast Cancer Research at the ICR, explains more.

Related Topic Pages
Anticancer Therapies
Advertisement
Chosen for You
A molecular look at antiobodies
Article

Are Monoclonal Antibodies the Future of Long COVID Treatments?
Three women scientists chatting in front of a white board
Article

Laura Eghobamien on Founding the Black Medical and Scientific Network and Advocating for Diversity in STEMM
A seaside town with a beach and sea in the foreground.
Article

Protecting Our Oceans Starts With Testing – Part One
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter